BIOMAT Database Logo BIOMAT Database Logo

Discovering novel 7-azaindole-based series as potent AXL kinase inhibitors. 2017

Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
OriBase Pharma, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 17383, 34189 Montpellier Cedex 4, France.

AXL is a receptor tyrosine kinase that plays a key role in tumor growth and proliferation. The scientific community has validated AXL as therapeutic target in the treatment of cancers for several years now, and several AXL inhibitors have been developed but none of them are approved. In this context, we started to design new kinase inhibitors targeting AXL from the 7-azaindole scaffold well known to interact with the ATP binding site of the kinase. Focused screening and chemical diversification around 7-azaindole scaffold were developed, based on modeling studies and medicinal chemistry rational, leading to the discovery of a new family of hits with potent inhibitory activity against AXL.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000094963 Axl Receptor Tyrosine Kinase A member of the Tyro3-Axl-Mer (TAM) RECEPTOR PROTEIN-TYROSINE KINASES subfamily. Involved in several cellular functions including growth, migration, cell aggregation, and anti-inflammation.
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures

Related Publications

Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity.
August 2017, ACS medicinal chemistry letters,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.
January 2016, European journal of medicinal chemistry,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors.
November 2020, ACS medicinal chemistry letters,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors.
June 2017, European journal of medicinal chemistry,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Discovery a series of quinazolin derivatives as potent AXL inhibitors.
July 2022, European journal of medicinal chemistry,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors.
April 2016, Journal of medicinal chemistry,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.
December 2008, ChemMedChem,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors.
January 2018, Chemical & pharmaceutical bulletin,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Synthesis and evaluation of C3 substituted chalcone-based derivatives of 7-azaindole as protein kinase inhibitors.
December 2020, Chemical biology & drug design,
Clémence Feneyrolles, and Léa Guiet, and Mathilde Singer, and Nathalie Van Hijfte, and Bénédicte Daydé-Cazals, and Bénédicte Fauvel, and Gwénaël Chevé, and Abdelaziz Yasri
Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitors.
September 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!